7Goodman S. Enoxaparin and glycoprotein lib / Ilia inhibition innon-ST-elevation acute coronary syndrome: insights from theINTERACT trial [J]. Am Heart J, 2005, 149(4Suppl): S73-S80.
8Kim JH, Jeong MH, Rhew JY, et al. Long-term clinical out-comes of platelet glycoprotein Ilb/IIIa inhibitor combined withlow molecular weight heparin in patients with acute coronarysyndrome [J]. Circ J,2005, 69(2):159-164.
9Giuqliano RP, Newby LK, Harrinqton RA, et al. The earlyglycoprotein II b/ IH a inhibition in non-ST-segment elevationacute coronary syndrome (EARLYACS) trial: a randomizedplacebo- controlled trial evaluating the clinical benefits ofearly front-loaded eptifibatide in the treatment of patients withnon-ST-segment elevation acute coronary syndrome-studydesign and rationale [J]. Am Heart J, 2005,149(6): 994.
10Santilli F, Davl G, Consoli A,et al. Thromboxane-dependentCD40 ligand release in type 2 diabetes mellitus [J]. J Am CollCardiol, 2006, 47(2):391-397.